MedTrace Logo

Blood Biomarker Signature in Glioma

NCT03698201 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 147

Last updated 2025-07-08

No results posted yet for this study

Summary

This is an exploratory, translational and non-interventional clinical study. The aim of this study is to identify a blood biomarker signature for glioma.

Conditions

  • Glioma of Brain

Interventions

OTHER

Non-interventional

Translational, observational study

Sponsors & Collaborators

  • Royal College of Surgeons, Ireland

    collaborator OTHER

  • Cancer Trials Ireland

    lead NETWORK

Principal Investigators

  • Jochen Prehn · Cancer Trials Ireland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03698201 on ClinicalTrials.gov